Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
15.88 x 1 22.99 x 1
Pre-market by (Cboe BZX)
20.88 -0.18 (-0.85%) 03/21/25 [NASDAQ]
15.88 x 1 22.99 x 1
Pre-market 20.88 unch (unch) 16:00 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
20.38
Day High
21.24
Open 20.70
Previous Close 21.06 21.06
Volume 81,300 81,300
Avg Vol 32,060 32,060
Stochastic %K 37.47% 37.47%
Weighted Alpha -25.13 -25.13
5-Day Change +0.44 (+2.18%) +0.44 (+2.18%)
52-Week Range 19.92 - 35.00 19.92 - 35.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 250,122
  • Shares Outstanding, K 11,979
  • Annual Sales, $ 4,760 K
  • Annual Income, $ -40,830 K
  • EBIT $ -52 M
  • EBITDA $ -52 M
  • 60-Month Beta 1.00
  • Price/Sales 8.86
  • Price/Cash Flow N/A
  • Price/Book 3.03

Options Overview Details

View History
  • Implied Volatility 102.84% ( -2.03%)
  • Historical Volatility 37.72%
  • IV Percentile 98%
  • IV Rank 96.62%
  • IV High 104.87% on 03/11/25
  • IV Low 44.82% on 06/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 15
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 109
  • Open Int (30-Day) 103

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.26
  • Number of Estimates 3
  • High Estimate -0.20
  • Low Estimate -0.31
  • Prior Year -0.86
  • Growth Rate Est. (year over year) +69.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.92 +4.82%
on 03/10/25
Period Open: 23.52
24.65 -15.29%
on 02/24/25
-2.64 (-11.22%)
since 02/21/25
3-Month
19.92 +4.82%
on 03/10/25
Period Open: 27.13
29.02 -28.05%
on 01/15/25
-6.25 (-23.04%)
since 12/20/24
52-Week
19.92 +4.82%
on 03/10/25
Period Open: 24.53
35.00 -40.34%
on 11/27/24
-3.65 (-14.88%)
since 03/21/24

Most Recent Stories

More News
XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA : 20.88 (-0.85%)
XOMAP : 25.77 (+0.74%)
XOMAO : 25.45 (-0.06%)
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements

XOMA : 20.88 (-0.85%)
XOMAP : 25.77 (+0.74%)
XOMAO : 25.45 (-0.06%)
Bank Rate Decision Due Next Week

U.S. Monday Featured Earnings Oracle Corporation (NYSE:ORCL) (Q3) EPS of $1.18, compared ...

BEKE : 20.96 (+1.55%)
XOMA : 20.88 (-0.85%)
ULTA : 358.42 (+2.24%)
EVEX : 3.76 (+5.03%)
MTN : 161.55 (+0.55%)
CCI : 106.22 (-0.16%)
ORCL : 155.64 (+2.24%)
DKS : 201.35 (+3.02%)
ENGH.TO : 26.46 (+0.46%)
BNTX : 95.90 (+0.55%)
GOGO : 7.57 (+2.02%)
FERG : 164.99 (+1.64%)
XOMA Royalty to Present at Investor Conferences in March

XOMA : 20.88 (-0.85%)
XOMAP : 25.77 (+0.74%)
XOMAO : 25.45 (-0.06%)
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

XOMA : 20.88 (-0.85%)
XOMAP : 25.77 (+0.74%)
XOMAO : 25.45 (-0.06%)
XOMA Royalty Corporation Announces Cash Dividends for Series A and Series B Preferred Stock

XOMA Royalty Corporation announces upcoming cash dividends for Series A and B Preferred Stock, payable January 15, 2025.Quiver AI SummaryXOMA Royalty Corporation has announced that its Board of Directors...

XOMA : 20.88 (-0.85%)
XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA : 20.88 (-0.85%)
XOMAP : 25.77 (+0.74%)
XOMAO : 25.45 (-0.06%)
XOMA Royalty Acquires Pulmokine, Adding Seralutinib as its Seventh Phase 3 Royalty Asset

XOMA Royalty acquires seralutinib, enhancing its Phase 3 royalty assets targeting pulmonary arterial hypertension.Quiver AI SummaryXOMA Royalty Corporation has acquired an economic interest in seralutinib,...

XOMA : 20.88 (-0.85%)
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

XOMA : 20.88 (-0.85%)
XOMAP : 25.77 (+0.74%)
XOMAO : 25.45 (-0.06%)
XOMA Royalty: Q3 Earnings Snapshot

XOMA Royalty: Q3 Earnings Snapshot

XOMA : 20.88 (-0.85%)

Business Summary

XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE,...

See More

Key Turning Points

3rd Resistance Point 22.15
2nd Resistance Point 21.69
1st Resistance Point 21.29
Last Price 20.88
1st Support Level 20.43
2nd Support Level 19.97
3rd Support Level 19.57

See More

52-Week High 35.00
Fibonacci 61.8% 29.24
Fibonacci 50% 27.46
Fibonacci 38.2% 25.68
Last Price 20.88
52-Week Low 19.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals